Intravenous hydrochloric acid by continuous infusion or acetazolamide, a carbonic anhydrase inhibitor, can be administered to correct metabolic alkalosis. The OLT recipient is at great risk for ...

After the administration of a single dose of the drug to this patient, the urine was examined for carbonic anhydrase inhibitor activity. Seventy-two per cent of the administered drug was recovered ...

A multidisciplinary, multi-organizational panel of experts in medical oncology, dermatology, gastroenterology, rheumatology, pulmonology, endocrinology, urology ...

Contribution from the Istituto di Biostrutture e Bioimmagini-CNR, via Mezzocannone 16, 80134 Naples, Italy, Dipartimento delle Scienze Biologiche-Sezione Biostrutture, University of Naples “Federico ...

Xopenex HFA (levalbuterol) has potential interactions with other medications and some supplements. These interactions could affect how well the drug works or cause harmful effects. An interaction ...

Previous, smaller studies had found that patients tended to gain weight while on the Janus kinase (JAK) inhibitor tofacitinib. This study, funded by tofacitinib's manufacturer, analyzed data from ...

Study will evaluate OX-4224 as a second-line monotherapy in patients with PD-L1–positive non-small cell lung cancer, expanding potential access to checkpoint inhibitors in low-resource settings ...

Acetazolamide-related hypophosphatemia leading to cardiac arrest is extremely rare. Herein we report a 78-year-old female glaucoma patient who developed general weakness and acute respiratory ...

Intra-patient comparison from larotrectinib clinical trials in TRK fusion cancer: An expanded dataset. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does not ...

CHANGES in the pH of the blood in disease are very small – that is, with limits of 7.0 to 7.8 in extraordinary circumstances. Considering that large variations occur in the amounts of hydrogen ...